DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Procter & Gamble Health Announces Second Quarter Results

EquityBulls 4 hrs ago·2 Nov 2026, 12:08 pm

Procter & Gamble Health L

Procter & Gamble Health (PGHL) has reported its financial performance for the second quarter, outlining its revenue and operational results for the period. The company has provided an update on its business activities and financial standing.

For investors, the release is a key indicator of the company's current market position and operational health. It offers insights into the demand for its healthcare products and the effectiveness of its business strategies. Understanding these results helps investors gauge the company's trajectory and its ability to maintain growth in the competitive healthcare sector.

Investors should monitor the company's future outlook and commentary on market conditions. Keeping an eye on the management's guidance for upcoming quarters will be crucial for assessing the company's continued performance and strategic direction.